Archive for 'Tag Archives: 'ULB''
Prestigious European Albert Renold Award granted to Professor Decio L. Eizirik of the Universite Libre de Bruxelles (ULB).
Dr. Decio L. Eizirik, Laboratory Director and Professor at the Medical Faculty, Université Libre de Bruxelles (ULB), since 2002, has been selected for the 2012 Albert Renold Prize by the European Association for the Study of [...]
Bone Therapeutics gets approval for pivotal phase III osteonecrosis trial in Europe and treats first patients with their Advanced Therapy Medicinal Product PREOB®
After receiving clearance from the competent authorities in Europe for its phase III pivotal osteonecrosis* trial with their second generation Advanced Therapy Medicinal Product (ATMP), PREOB®, bone regenerative medicine company Bone Therapeutics recently announced that their [...]
Human Waves (ULB and UMons, Belgium) having positive effect on the brain, providing services to improve sport performances and mental disorders
Human Waves, a spin-off born from Université Libre de Bruxelles (ULB) and Université de Mons (UMons), is developing products and services in neurotechnology adapted to solving health problems as well as helping athletes improve their performance [...]
International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.
Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]
Prestigious international stem cell award (ISSCR) is granted to Belgian Dr. Cédric Blanpain (FNRS-ULB/WELBIO).
The ISSCR (International Society of Stem Cell Research), an organization bringing together top specialists worldwide, has named Dr. Cédric Blanpain as the recipient of the fourth annual ISSCR-University of Pittsburgh Outstanding Young Investigator Award. For the first time, [...]